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Leber congenital amaurosis (LCA) is one of the main causes of childhood blindness. To date, mutations in eight genes
have been described, which together account for ∼45% of LCA cases. We localized the genetic defect in a consanguineous
LCA-affected family from Quebec and identiﬁed a splice defect in a gene encoding a centrosomal protein (CEP290). The
defect is caused by an intronic mutation (c.2991+1655ArG) that creates a strong splice-donor site and inserts a cryptic
exon in the CEP290 messenger RNA. This mutation was detected in 16 (21%) of 76 unrelated patients with LCA, either
homozygously or in combination with a second deleterious mutation on the other allele. CEP290 mutations therefore
represent one of the most frequent causes of LCA identiﬁed so far.
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Leber congenital amaurosis (LCA [MIM 204000]) is a se-
vere retinal dystrophy, causing blindness or severe visual
impairment at birth or during the ﬁrst months of life. LCA
is generally inherited in an autosomal recessive manner
and is genetically heterogeneous. To date, mutations in
eight genes (AIPL1, CRB1, CRX, GUCY2D, IMPDH1,
RDH12, RPE65, and RPGRIP1) have been found to be as-
sociated with LCA.1–3 Mutations in each of these genes
have been identiﬁed in 2%–15% of patients with LCA,
and, together, these eight genes account for ∼45% of all
LCA cases.4–8
We ascertained a consanguineous FrenchCanadian fam-
ily with four sibs affected by LCA (ﬁg. 1A), and we ex-
cluded the involvement of all known LCA genes except
IMPDH1. A genomewide linkage scan was performed to
localize the causative gene defect. The four affected sib-
lings were genotyped with 11,555 SNPs spread throughout
the genome (Affymetrix GeneChip Human Mapping 10K
Array). Multipoint linkage analysis was performed with
Allegro9 version 1.2c in the easyLINKAGE-Plus software
package,10 with use of the white allele frequencies. We
identiﬁed four chromosomal intervals with multipoint
LOD scores 12. All four regions were analyzed with poly-
morphic CA-repeat markers in the mother, the four af-
fected sibs, and ﬁve unaffected sibs. Haplotype analysis
excluded two of these regions. The highest multipoint
LOD scores (2.9 and 3.0) were obtained at two chromo-
somal intervals: 12q21-q22 (rs950017–rs1385060) and
15q26 (rs1384739–rs725213). The region on chromosome
15 contained only one gene (MCTP2), which encoded a
multiple C2-domain transmembrane protein. The coding
exons and splice junctions were analyzed for mutations,
but only known variants were detected.
The region on chromosome 12 contained 15 genes, in-
cluding CEP290 (or NPHP6 [MIM 610142]) (ﬁg. 1A). Mu-
tations in this gene have recently been associated with
pleiotropic forms of Joubert syndrome.11,12 Joubert syn-
drome is an autosomal recessive disorder characterized by
neurological features, including psychomotor delay, hy-
potonia, and ataxia. A typical neuroradiological feature of
Joubert syndrome is the “molar tooth sign,” indicating
hypoplasia or aplasia of the cerebellar vermis. In addition
to neurological features, patients with Joubert syndrome
can develop nephronophthisis and retinal dystrophy. The
clinical spectrum of Joubert syndrome associated with
CEP290 mutations is broad. Neurological symptoms typ-
ical of Joubert syndrome are present in all patients, but
renal disease is either severe or absent. All analyzed pa-
tients have congenital amaurosis or retinitis pigmentosa.
Nearly all patients carry nonsense or frameshift mutations
on both alleles. An in-frame deletion in the Cep290 gene
was also recently associated with early-onset retinal de-
generation in the rd16mouse.13 After extensive evaluation,
no gross brain or kidney pathology could be detected in
these mice. CEP290 localizes to the centrosomes of divid-
ing cells and to the connecting cilium of photoreceptors.
CEP290 associates with several microtubule-based trans-
port proteins, including RPGR, a protein that is mutated
in patients with X-linked retinitis pigmentosa and cone-
rod dystrophy.
Figure 1. Pedigree and clinical features of the French Canadian LCA-affected family. A, Pedigree of the family. Four siblings are affected
with LCA (blackened symbols), and the parents are ﬁrst cousins. Haplotypes are shown for the chromosome 12 interval containing
CEP290. B–E, Color fundus photographs of the right eye of affected sib IV-8 at age 45 years. B, Posterior pole, showing myopic changes,
choroidal show, mild optic disc pallor, very signiﬁcant arteriolar and venular narrowing, a poorly developed fovea, and peri-papillary
atrophy, which extends along the superior arcade. C, Superior retina, showing a small isolated area of pigmentation, one bone spicule,
and diffuse choroidal show. D, Inferior retina, showing small clumps of round pigmentation. E, Inferotemporal retina, showing more
extensive small, round intraretinal pigmentation (nummular pigmentation). Images are slightly blurred because of a mild nuclear cataract.
F, CT scan at the level of the midbrain of proband IV-7 at age 40 years. The axial view of the brain shows the normal structures of the
midbrain and the cerebellum, without the molar tooth sign. G, CT scan of proband IV-7 at age 40 years at the level of the basal ganglia
and the ventricles, depicting normal brain architecture, with no cerebellar atrophy. H and I, Kidney ultrasounds of affected sibling IV-
6 at age 51 years. At the level of the parenchyma, both kidneys show isolated tiny foci of marked increased echogenicity, but without
deﬁnite posterior shadowing. These are located mostly on the left side at the level of the cortex, but a few are also identiﬁed near
the medulla on both sides and may indicate the presence of nephrocalcinosis. On both images, there are neither deﬁnite cysts nor
dilatation of the collecting system or ureteral dilatation. There is no evidence of nephronophthisis.
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Figure 2. Molecular characterization of the CEP290 mutation in
the consanguineous LCA-affected family. A, Reverse transcription
of CEP290 mRNA and subsequent PCR using primers situated in
exons 26–29 in two affected family members (IV-6 and IV-7),
revealing a fragment of normal size and a larger aberrant fragment
(upper panel). The aberrant fragment was not present in eight
control individuals (C1–C8). RT-PCR using primers situated in the
cryptic exon (X) and in exon 29 revealed an aberrant fragment in
the patients with LCA but not in the controls (lower panel). Lane
M contains a 100-bp marker. B, Sequencing of the aberrant RT-
PCR product, showing that a cryptic exon (X) is spliced in between
exons 26 and 27. The cryptic exon introduces a premature stop
codon immediately downstream of exon 26. C, Cryptic exon X lo-
cated 1.5 kb downstream of exon 26. Sequencing of the genomic
DNA (gDNA) surrounding exon X revealed a mutation 5 bp down-
stream of the cryptic exon (c.29911655ArG). The mutation in-
troduces a strong splice-donor site. Nucleotides in the cryptic exon
are in uppercase letters, and intronic sequences are in lowercase
letters. D, Allele-speciﬁc PCR showed that the c.29911655ArG
mutation segregates with the disease in the family. All affected
family members (IV-6, IV-7, IV-8, and IV-9) are homozygous for
the mutation, whereas unaffected individuals are heterozygous or
do not carry the mutation. Lane C represents a control individual.
The affected individuals of the French Canadian LCA-
affected family were all blind or severely visually impaired
at birth and showed wandering nystagmus since age ∼6
wk. Patient IV-7 was ﬁrst seen by us when he was age 43
years, and we observed that he had light-perception vi-
sion, with the oculodigital sign and enophthalmos. We
also noted mild microphthalmia, a hyperopic refraction,
marked keratoconus, dense white cataracts, ectopia lentis,
and a pigmentary retinal degeneration with nummular
pigmentations. Visual function was remarkably variable
in the four affected sibs, ranging from light perception in
patients IV-6 and IV-7 to more functional vision (20/150
acuities) in patient IV-8 and tunnel vision (30) with 20/
80 acuities in patient IV-9. The retinal aspect of patient
IV-8, who has a myopic astigmatic refraction, is shown in
ﬁgure 1B–1E. Two of the four affected sibs (IV-6 and IV-
7) experienced seizures, which is not typical for Joubert
syndrome, and had no other neurological symptoms. All
four affected sibs had normal cognitive function. Detailed
CT scanning (repeated ﬁve times) in patient IV-7 revealed
no molar-tooth sign, no cerebellar atrophy, and no struc-
tural signs of Joubert syndrome (ﬁg. 1F and 1G). The pro-
band and the affected sibs are now in their 40s and 50s
and have never exhibited any clinical signs of renal dis-
ease. Patient IV-6 had normal kidneys on renal ultrasound
at age 51 years (ﬁg. 1H and 1I).
Because of its function and the phenotype of rd16 mice,
we considered CEP290 to be an excellent candidate gene
for LCA in this French Canadian family. We sequenced
all 53 coding exons and splice junctions and detected
only one synonymous sequence variant (c.2055TrC
[p.A685A]) in exon 21, which was not a known SNP. Since
the variant is located between the splice-donor site and a
predicted exonic splice enhancer (RESCUE-ESE14), we rea-
soned that it may have an effect on the splicing of this
exon. However, RT-PCR performed on RNA isolated from
an Epstein-Barr virus–immortalized lymphoblastoid cell
line of patient IV-6 did not reveal aberrant splicing of ex-
on 21. Subsequently, we analyzed the complete CEP290
mRNA by RT-PCR, using 21 overlapping primer sets. An
aberrant splice product was detected with a primer set
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Table 1. CEP290 Mutations in Patients with LCA
Patient Country
Allele 1 Allele 2
Mutation Effect Mutation Effect
12832 Netherlands c.29911655ArG p.Cys998X c.29911655ArG p.Cys998X
13168 Germany c.29911655ArG p.Cys998X c.2249TrG p.Leu750X
14964 Germany c.29911655ArG p.Cys998X c.7341dupA p.Leu2448ThrfsX7
15103 Germany c.29911655ArG p.Cys998X c.2118_2122dupTCAGC p.Thr709SerfsX8
15212 Germany c.29911655ArG p.Cys998X c.5866GrT p.Glu1956X
16317 Netherlands c.29911655ArG p.Cys998X c.29911655ArG p.Cys998X
17971 Netherlands c.29911655ArG p.Cys998X c.3814CrT p.Arg1272X
20152 Netherlands c.29911655ArG p.Cys998X c.679_680delGA p.Glu227SerfsX1
21365 Netherlands c.29911655ArG p.Cys998X c.29911655ArG p.Cys998X
21393 Netherlands c.29911655ArG p.Cys998X c.265dupA p.Thr89AsnfsX1
21918 Netherlands c.29911655ArG p.Cys998X c.1801GrT Splice defect
27228 Canada c.29911655ArG p.Cys998X c.29911655ArG p.Cys998X
27242 Canada c.29911655ArG p.Cys998X c.1550delT p.Leu517X
27245 Canada c.29911655ArG p.Cys998X c.4115_4116delTA p.Ile1372LysfsX4
27246 Canada c.29911655ArG p.Cys998X c.4966GrT p.Glu1656X
27250 Italy c.29911655ArG p.Cys998X c.5813_5817delCTTTA p.Thr1938AsnfsX15
Figure 3. Segregation analysis of CEP290 mutations in nine LCA-affected families. In all nine families, segregation of the mutations
is in agreement with autosomal recessive inheritance. For each family, the proband is indicated (arrow). M1 p c.29911655ArG;
M2 p p.Glu1956X; M3 p p.Arg1272X; M4 p p.Thr89AsnfsX1; M5 p c.1801GrT; M6 p p.Leu517X; M7 p p.Ile1372LysfsX3;
M8 p p.Glu1656X;  p wild type.
designed to amplify exons 26–29 (ﬁg. 2A). Sequencing of
the product revealed the insertion of a 128-bp cryptic exon
between exons 26 and 27, which introduces a stop codon
immediately downstream of exon 26 (ﬁg. 2B). Notably, a
small amount of wild-type product is still present in the
affected individuals. The aberrant splice product was not
detected in eight control individuals (ﬁg. 2A).
The sequence of the cryptic exon is located in intron
26, 1.5 kb downstream of exon 26, and contains part of
an Alu element. In the wild-type sequence, the exon is
preceded by a strong splice-acceptor site (splice predic-
tion score 0.93), but no splice-donor site is predicted
(NNSPLICE version 0.9; BDGP Splice Site Prediction by
Neural Network Web site).15 We sequenced the genomic
DNA surrounding the cryptic exon in patient IV-6 and
detected an ArG transition 5 bp downstream of the cryp-
tic exon (c.29911655ArG) (ﬁg. 2C). The mutation cre-
ates a strong splice-donor site (splice prediction score
0.90), which presumably leads to efﬁcient splicing of the
cryptic exon into the CEP290 mRNA. The mutation seg-
regates with the disease in the family (ﬁg. 2D).
To determine whether this mutation could be a com-
mon cause of LCA, we screened 76 unrelated patients with
LCA for the c.29911655ArG mutation by allele-speciﬁc
PCR.16 The involvement of known LCA genes was previ-
ously excluded in these patients by microarray-based mu-
tation detection6 and/or comprehensive heteroduplex anal-
ysis. Strikingly, 4 patients were homozygous for the
mutation, and 12 were heterozygous for c.29911655ArG
(table 1). The mutation was not detected in 223 French
Canadian controls, and 1 of 248 Dutch control individuals
was found to be heterozygous for the mutation.
These results indicate that the c.29911655ArG mu-
tation is an important cause of LCA and may explain up
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to 21% of LCA cases. Under the assumptions of an overall
incidence of LCA of 1/100,000 individuals in the white
population and the involvement of CEP290 mutations in
10% of patients with LCA, the Hardy-Weinberg equation
predicts a total CEP290 mutant allele frequency of 1/1,000
and a carrier frequency of 1/500 individuals. Under the
assumption that the c.29911655ArG variant constitutes
two-thirds of all mutant alleles, a carrier frequency of 1/
750 individuals is predicted. If CEP290 variants underlie
30% of LCA cases, a carrier frequency of 1/433 individuals
is predicted.
The 12 patients who were heterozygous for c.2991
1655ArG were analyzed for additional mutations in the
53 coding exons and splice junctions of CEP290 by het-
eroduplex analysis and/or direct sequencing. In all pa-
tients, we detected a heterozygous mutation on the other
allele (table 1). Five mutations introduce a premature stop
codon, six lead to a frameshift, and one affects the in-
variable GT dinucleotide of the splice-donor site of
exon 3.
In nine families in which two CEP290 mutations were
identiﬁed, family members were available for segregation
analysis. In all nine families, segregation of the variants
as expected for autosomal recessive inheritance was ob-
served (ﬁg. 3). Patients had no neurological symptoms
typical of Joubert syndrome, had normal cognitive func-
tion, and showed no clinical signs of renal disease. Patient
21393 had abnormal proprioception but was otherwise
healthy. Clinical details of four representative patients are
given below.
Patient 27245 is a male baby who was ﬁrst seen by us
when he was age 10 mo. His head circumference was
found to be large by a pediatrician, and he underwent
magnetic resonance imaging and ultrasound of the brain,
which were found to be normal by a pediatric neurora-
diologist. Ultrasound studies of both kidneys also hadnor-
mal ﬁndings. On ophthalmic evaluation, we found that
the child had no ﬁxation and did not follow a near target.
He exhibited the oculodigital sign, and refractions re-
vealed a marked hyperopia. Retinal examination showed
narrow vessels, mottled retinal pigment epithelium, and
multiple white intraretinal dots. Electroretinogram (ERG)
testing revealed nondetectable rod and cone responses.
Patient 27242 also had a completely normal brain CT.
On eye examination at age 7 mo, no visual behavior was
seen, and there was no ﬁxation and no following of a
target. She exhibited the oculodigital sign, nystagmus, and
high hyperopia. The retinal appearance was essentially
normal, with mild vascular attenuation. The ERG signals
were nondetectable.
At age 18 mo, patient 27246 did not exhibit visual be-
havior and had wandering nystagmus, the oculodigital
sign, high hyperopia, and nondetectable ERG signals. The
retinal appearance was essentially normal. Patient 27250
was also blind at birth, with light-perception vision, and
we documented posterior pole cataracts, keratoconus, and
nondetectable ERG signals.
The CEP290 c.29911655ArG mutation was detected
in 16 (21%) of 76 unrelated patients with LCA and thus
represents one of the most frequent causes of LCA iden-
tiﬁed so far. Patients carrying this mutation originate from
various geographic regions, including Canada, Germany,
The Netherlands, and Italy. Themutation leads to aberrant
splicing, but a small amount of correctly spliced product
is still present, which suggests that this may be sufﬁcient
for normal cerebellar and renal function but not for cor-
rect function of the photoreceptors. Complete loss of
function of bothCEP290 alleles leads to Joubert syndrome,
whereas patients with LCA have a small amount of resid-
ual CEP290 activity. This dosage-dependent mechanism is
similar to earlier ﬁndings for the ABCA4 gene, implicated
in Stargardt disease, cone-rod dystrophy, and retinitis pig-
mentosa, and for the USH2A gene, which has been asso-
ciated with nonsyndromic retinitis pigmentosa andUsher
syndrome.17,18
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